Title:
【発明の名称】ヒト腫瘍壊死因子に対するモノクローナル抗体を含有する敗血症治療薬及びリューマチ性疾患治療薬
Document Type and Number:
Japanese Patent JP2837160
Kind Code:
B2
Abstract:
The monoclonal antibodies are directed highly specifically against human tumour necrosis factor and are synthesised by hybridoma cell lines prepared as described. ……
More Like This:
| JP2000500661 | [Title of Invention] CD6 Ligand |
| WO/1995/014929 | DIMERIC OLIGOPEPTIDE MIXTURE SETS |
| WO/1998/020020 | HIGH DENSITY IMMOBILIZATION OF NUCLEIC ACIDS |
Inventors:
AKIMU MERAA
FURANTSU EMURINGU
FURANTSU EMURINGU
Application Number:
JP22675587A
Publication Date:
December 14, 1998
Filing Date:
September 11, 1987
Export Citation:
Assignee:
BEE AA ESU EFU AG
International Classes:
G01N33/53; A61K39/395; A61P29/00; A61P31/04; A61P35/00; C07H21/04; C07K14/00; C07K14/005; C07K14/195; C07K14/52; C07K14/525; C07K16/00; C07K16/24; C12N5/10; C12N5/20; C12N15/00; C12N15/02; C12P21/00; C12P21/08; G01N33/577; C12R1/91; (IPC1-7): A61K39/395; A61K39/395
Other References:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS=1986
Attorney, Agent or Firm:
Toshio Yano (2 outside)